FDA To Release Warning Letter Responses, Sans Some Related Materials
This article was originally published in The Gray Sheet
Executive Summary
A six-month pilot program to post FDA warning letter responses on the agency's website, at the recipient's request, will elevate the profile of companies seeking to allay compliance concerns